BOUL — Boule Diagnostics AB Share News
0.000.00%
- SEK139.41m
- SEK342.91m
- SEK489.69m
Brief: Boule Diagnostics Appoints Simonetta Tumbiolo As Interim CEO
Brief: Boule Reports Q1 Net Sales Down At SEK 101.6 Million
Brief: Boule Diagnostics Q4 Net Sales Down At Sek 120.2 Million
Brief: Boule Diagnostics Renews, Expands Global Supply Agreement
Brief: Boule Diagnostics Appoints Michael Af Winklerfelt As CFO
Brief: Boule Diagnostics Selected As Provider In Tender In Italy
Brief: Boule Diagnostics CEO Torben Nielsen To Leave Company
Brief: Boule Diagnostics Q3 Adjusted Operating Profit Falls To SEK 12.0 Mln
Brief: Boule Diagnostics CFO Leaves Company
Brief: Boule Diagnostics Q2 Operating Profit Down At SEK 1.3 Mln
Brief: Boule Diagnostics Q1 Adj Oper Profit At SEK 17.0 Mln
Brief: Boule Diagnostics Closes BM950 Project, Announces New Portfolio Strategy
Brief: Boule Diagnostics Q4 Adjusted Operating Profit SEK 19.5 Mln
Brief: Boule Diagnostics Signs Distribution Agreement With Vitalscientific
Brief: Boule Diagnostics Q3 Adj Oper Profit Rises To SEK 15.3 Mln
Brief: Boule Diagnostics: Recognized Non-Cash One-Off Cost Of SEK 265 Mln In Q3
Brief: Boule Diagnostics Q2 Adj Operating Profit Up At SEK 9.9 Mln
Brief: Boule Diagnostics AB Says AGM Resolved That No Dividend Would Be Paid For Financial Year 2023.
Brief: Boule Diagnostics Q1 Operating Profit Up At SEK 15.4 Mln